Bluejay Diagnostics
BJDX
6 hedge funds and large institutions have $258K invested in Bluejay Diagnostics in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
200% more funds holding
Funds holding: 2 → 6 (+4)
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
163% more capital invested
Capital invested by funds: $98K → $258K (+$160K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$70.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$35.5K |
| 3 |
Millennium Management
New York
|
+$35.5K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$35.5K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$35.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$25K |
| 2 |
BlackRock
New York
|
-$23K |
| 3 |
Jane Street
New York
|
-$18K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $54K | +$70.9K | +2 | New |
|
|
VF
2
Virtu Financial
New York
| $45K | +$35.5K | +1 | New |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $35K | +$35.5K | +1 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| $32K | +$35.5K | +1 | New |
|
|
5
Millennium Management
New York
| $27K | +$35.5K | +1 | New |
|
|
TSS
6
Two Sigma Securities
New York
| $23K | +$35.5K | +1 | New |
|
7
Verition Fund Management
Greenwich,
Connecticut
| $16K | – | – | – |
|
8
Geode Capital Management
Boston,
Massachusetts
| $13K | – | – | – |
|
9
Northern Trust
Chicago,
Illinois
| $12K | – | – | – |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
|
11
BlackRock
New York
| – | -$23K | -1 | Closed |
|
|
PCM
12
Perkins Capital Management
Wayzata,
Minnesota
| – | -$25K | -1 | Closed |
|
|
13
Jane Street
New York
| – | -$18K | – | – |
|
|
TRCT
14
Tower Research Capital (TRC)
New York
| – | -$8K | – | – |
|
BJDX Hedge Fund Activity: Q2 2022 in Review
6 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q2 2022, worth a combined $258K — up 163% from $98K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new BJDX positions and 2 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $70.9K. The largest seller was Perkins Capital Management, exiting entirely with an estimated $25K sold.
- 6 institutional investors held Bluejay Diagnostics (BJDX) as of Q2 2022, up from 2 in Q1 2022.
- Funds reported $258K of Bluejay Diagnostics stock for Q2 2022, up 163% quarter-over-quarter.
- 6 funds opened new Bluejay Diagnostics positions in Q2 2022 and 2 closed out, a net change of +4 holders.
- The largest Bluejay Diagnostics buyer in Q2 2022 was Renaissance Technologies, an estimated $70.9K added.
- The largest Bluejay Diagnostics seller in Q2 2022 was Perkins Capital Management, an estimated $25K sold.
Based on aggregated 13F filings for Q2 2022.